We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company


Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routin... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Stago Launches New My Qualiris QC Website for Brand-New User Experience

By LabMedica International staff writers
Posted on 28 Jan 2022
Print article
Image: My Qualiris QC (Photo courtesy of Stago)
Image: My Qualiris QC (Photo courtesy of Stago)

Stago (Paris, France) has launched its new My Qualiris QC website which provides a brand-new user experience with a 24/7 accessible web-application where the results of a user’s network are only a few clicks away.

My Qualiris QC provides an easy-to-use and comprehensive External Quality Assessment service that will meet the daily and special coagulation testing needs of laboratories. To optimize the quality approach of laboratories, Stago had introduced the My Qualiris QC program more than 10 years ago. Built on Stago's expertise in hemostasis, My Qualiris QC carries out complete comparisons designed in accordance to the NF EN ISO/IEC 17043 standard to ensure reliability of results.

My Qualiris QC estimates global performance through an extensive multi-level comparison to ensure system accuracy. Stago’s color-coded reports and alerts are easy to interpret, and they include haemostasis-specific indicators. The new My Qualiris QC website allows laboratories to manage different user profiles, submit results and consult the available reports whenever they want. The dedicated, secured, multilingual website also allows laboratories to archive their results for five years and download their participation certificate for audits.

Related Links:
Stago: My Qualiris QC

Gold Supplier
SARS-CoV-2 Antigen Test
NG-Test SARS-NG-Test SARS-CoV-2 Ag Cassette
High-Throughput Nucleic Acid Extractor
Stream SP96
Washer Dispenser
Gold Supplier
Automatic Biochemistry Analyzer
Biossays C8

Print article


Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more


view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.